AI Article Synopsis
- The study investigates the relationship between metabolic syndrome (Mets) and depressive disorders (DD) by comparing patients with Mets to those without, focusing on features like cognitive impairment and severity of depression.
- Results show that patients with Mets exhibit more severe depressive symptoms, greater somatic anxiety, and higher rates of dementia compared to those without Mets, indicating a significant connection between metabolic health and mental health.
- A notable correlation was found between the severity of depression and cognitive function in patients with Mets, suggesting that metabolic components, particularly high triglycerides, may influence the severity of depressive symptoms.
Article Abstract
Introduction: Metabolic dysregulation is intimately associated with wide array of seemingly unrelated disorders, including cognitive impairment and depression. The aim was: to identify special characteristic features of depressive disorder in patients with metabolic syndrome (Mets); to identify possible association between depressive disorder (DD) and cognitive impairment in patients with Mets; to establish whether metabolic syndrome and its components are associated with severity of DD.
Materials And Methods: The study group consisted of 108 patients with depressive disorders aged from 45 to 84 years. All patients were divided into two groups: main- with Mets (n=60) and control - without metabolic syndrome (n=48), comparable for age, sex and level of education. The examination consisted of physical and neurological examination and the application of neuropsychological tests (Mini-Mental State Examination/MMSE, Hamilton Depression Rating Scale / HAM-D) magnetic resonance imaging and laboratory tests.
Results: It has been found more pronounced severity of depressive disorder (DD) in patients with Mets compared with patients without it (p<0,05). In the group of patients with Mets there was significantly higher incidence of somatic anxiety (p <0,01), hypochondria (p <0,05), reduced criticality (p <0,05) compared with patients without Mets. It has been found significantly higher incidence of dementia in patients with DD and Mets comparing with patients with DD without Mets (p<0,05). Statistically significant negative correlation was found between the total score on the Hamilton scale and the total MMSE score (r = -0,56, p <0.05) only in the group of patients with Mets. Of all Mets components a reliable positive correlation was found only between high triglyceride levels of blood and the total Hamilton scale score (rs = 0,27).
Conclusions: Our study adds to the mounting evidence that links depression and Mets. Some specific features of DD in patients with MetS were established. The severity of DD was significantly associated with severity of cognitive impairment in patients with Mets. Of all components of Mets, only elevated levels of triglycerides of blood was significantly associated with the severity of DD in our maim group of patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.
PLoS One
January 2025
Center of Excellence in Probiotics, Srinakharinwirot University, Bangkok, Thailand.
Modern treatment, a healthy diet, and physical activity routines lower the risk factors for metabolic syndrome; however, this condition is associated with all-cause and cardiovascular mortality worldwide. This investigation involved a randomized controlled trial, double-blind, parallel study. Fifty-eight participants with risk factors of metabolic syndrome according to the inclusion criteria were randomized into two groups and given probiotics (Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1) (n = 31) or a placebo (n = 27).
View Article and Find Full Text PDFDevelopment and validation of a metabolic syndrome and its components to predict the efficacy of neoadjuvant chemotherapy in breast cancer: An observational, single-center, cohort study.
Medicine (Baltimore)
January 2025
Department of Thyroid and Breast Surgery, Hebei General Hospital, Shijiazhuang, Hebei Province, China.
To assess whether metabolic syndrome can be used as a reference index to evaluate the efficacy of neoadjuvant chemotherapy treatment for breast cancer (BC). Seventy cases of female BC patients who received neoadjuvant chemotherapy treatment and surgical treatment at the Glandular Surgery Department of Hebei Provincial People's Hospital from January 2021 to December 2023 were retrospectively collected, and clinical data such as puncture pathology were recorded. The clinical data were analyzed by 1-way analysis using the χ2 test, and further multifactorial logistic regression analysis was performed for statistically significant differences.
View Article and Find Full Text PDFHearing loss in patients with Morquio A syndrome: A scoping review.
Medicine (Baltimore)
January 2025
Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia.
Background: Hearing impairment is a prevalent clinical feature in Morquio syndrome (mucopolysaccharidosis IVA or MPS IVA) patients, often presenting in diverse forms: conductive, sensorineural, or a combination known as mixed hearing loss. The mixed form entails a blend of both conductive and sensorineural elements, typically exhibiting a progressive trajectory. This scoping review aimed to comprehensively analyze available evidence pertaining to the pathophysiology, classification, epidemiology, and clinical management of hearing loss in individuals with MPS IVA.
View Article and Find Full Text PDFMulti-miRNAs-Mediated Hepatic Lepr Axis Suppression: A Pparg-Dicer1 Pathway-Driven Mechanism in Spermatogenesis for the Intergenerational Transmission of Paternal Metabolic Syndrome.
Adv Sci (Weinh)
January 2025
Fujian Key Laboratory of Coastal Pollution Prevention and Control, Xiamen University, Xiamen, 361102, China.
Bisphenol A (BPA) is an "environmental obesogen" and this study aims to investigate the intergenerational impacts of BPA-induced metabolic syndrome (MetS), specifically focusing on unraveling mechanisms. Exposure to BPA induces metabolic disorders in the paternal mice, which are then transmitted to offspring, leading to late-onset MetS. Mechanistically, BPA upregulates Srebf1, which in turn promotes the Pparg-dependent transcription of Dicer1 in spermatocytes, increasing the levels of multiple sperm microRNAs (miRNAs).
View Article and Find Full Text PDFA comprehensive systemic review and meta-analysis of the association between lipid profile and hidradenitis suppurativa.
Arch Dermatol Res
January 2025
Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan.
Background: While several studies have suggested a connection between Metabolic Syndrome (MetS) and Hidradenitis Suppurativa (HS), a definitive analysis confirming the association between lipid abnormalities and HS based on actual lipid values is lacking. Previous research, using odds ratios from ICD codes, indicates links between elevated triglycerides and low high-density lipoprotein levels with HS. However, these findings may not fully represent real-life situations, as no comprehensive analysis using actual lipid measurements has been performed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!